Two systematic reviews by US federal agencies on the possible link between antiviral treatment for COVID-19 and viral rebound—one specifically on Paxlovid—find no consistent association. The studies were published yesteray in Morbidity and Mortality Weekly Report.
...
Problem, Solution, SitRep, or ?:
Recent Comments